These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9922584)

  • 1. [The role of the GH/IGF-1 axis in cardiovascular physiopathology and therapy: the lessons from animal studies].
    Cittadini A; Durante Mangoni E; Palmieri EA; Casaburi C; Longobardi S; Di Rella F; Fazio S; Saccà L
    Cardiologia; 1998 Nov; 43(11):1185-92. PubMed ID: 9922584
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models.
    Yakar S; Leroith D; Brodt P
    Cytokine Growth Factor Rev; 2005; 16(4-5):407-20. PubMed ID: 15886048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IGF-1 in glucose regulation and cardiovascular disease.
    Abbas A; Grant PJ; Kearney MT
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1135-49. PubMed ID: 18793116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone and the cardiovascular function.
    Svensson J; Tivesten A; Isgaard J
    Minerva Endocrinol; 2005 Mar; 30(1):1-13. PubMed ID: 15877009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of growth hormone and insulin-like growth factor-1 on the aging cardiovascular system and its progenitor cells.
    Devin JK; Young PP
    Curr Opin Investig Drugs; 2008 Sep; 9(9):983-92. PubMed ID: 18729005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does growth hormone play a role in chronic heart failure?
    Volterrani M; Giustina A; Lorusso R; Giordano A
    Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies involving the GH-IGF axis: Lessons from IGF-I and IGF-I receptor gene targeting mouse models.
    Yakar S; Pennisi P; Kim CH; Zhao H; Toyoshima Y; Gavrilova O; LeRoith D
    J Endocrinol Invest; 2005; 28(5 Suppl):19-22. PubMed ID: 16114270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH, IGF-I, and growth.
    Isaksson O
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1321-6. PubMed ID: 15506078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth factor therapy for heart failure: IGF-1].
    Komamura K
    Nihon Rinsho; 2007 May; 65 Suppl 5():182-6. PubMed ID: 17571382
    [No Abstract]   [Full Text] [Related]  

  • 15. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts: growth hormone, insulin-like growth factor-I and the kidney.
    Rabkin R; Schaefer F
    Growth Horm IGF Res; 2004 Aug; 14(4):270-6. PubMed ID: 15231295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
    Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
    Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the somatotropic system in cognition and other cerebral functions.
    Creyghton WM; van Dam PS; Koppeschaar HP
    Semin Vasc Med; 2004 May; 4(2):167-72. PubMed ID: 15478038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ghrelin in the treatment of cardiovascular disease].
    Nagaya N; Kangawa K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():430-4. PubMed ID: 15506421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.